Faron Pharmaceuticals Oy (LON:FARN) shares passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $425.10 and traded as low as $331.00. Faron Pharmaceuticals Oy shares last traded at $367.50, with a volume of 289,482 shares changing hands.
The stock has a market capitalization of $196.56 million and a price-to-earnings ratio of -3.36. The business has a fifty day moving average of GBX 425.10 and a 200 day moving average of GBX 390.34. The company has a debt-to-equity ratio of 37.91, a current ratio of 2.98 and a quick ratio of 2.62.
About Faron Pharmaceuticals Oy (LON:FARN)
Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company in Finland. It has a pipeline of drug development projects focusing on acute organ traumas, vascular damage, and cancer immunotherapy. The company's lead product candidate is Traumakine, a recombinant human IFN beta-1a, which is in Phase III clinical trial for the treatment of acute respiratory distress syndrome (ARDS).
See Also: What is the definition of market timing?
Receive News & Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related companies with MarketBeat.com's FREE daily email newsletter.